

All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
Oct 20, 2023
Jacob Robinson, an entrepreneurial scientist and CEO of Motif Neurotech, discusses the future of mental health treatment through innovative neuromodulation implants aimed at depression. Joined by Brom Rector of Empath Ventures, they unveil how these minimally invasive devices could revolutionize psychiatry, offering alternatives to traditional drug therapies. The conversation touches on ethical considerations, challenges of accessibility, and the differentiation between Motif and Neuralink. They also explore the transition from academic research to innovative entrepreneurship in the neurotechnology space.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 3min
Advancing Neuromodulation for Mental Health
02:53 • 22min
Neurotechnology and Mental Health: Ethical Considerations
24:54 • 13min
Comparing Neurotech Implants: Motif vs. Neuralink
37:25 • 3min
Exploring the Future of Brain-Computer Interfaces and Talent Acquisition
40:22 • 4min
Navigating the Transition from Academia to Entrepreneurship
44:18 • 2min
From Academia to Entrepreneurship: Navigating Funding Challenges
46:38 • 8min